These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 18479073

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Oral vaccine delivery by recombinant spore probiotics.
    Cutting SM, Hong HA, Baccigalupi L, Ricca E.
    Int Rev Immunol; 2009; 28(6):487-505. PubMed ID: 19954360
    [Abstract] [Full Text] [Related]

  • 5. [Vaccination strategies for anthrax prevention].
    Beyer W.
    Berl Munch Tierarztl Wochenschr; 2004; 117(11-12):508-24. PubMed ID: 15584433
    [Abstract] [Full Text] [Related]

  • 6. Oral vaccination with envelope protein VP28 against white spot syndrome virus in Procambarus clarkii using Bacillus subtilis as delivery vehicles.
    Fu LL, Li WF, Du HH, Dai W, Xu ZR.
    Lett Appl Microbiol; 2008 May; 46(5):581-6. PubMed ID: 18373657
    [Abstract] [Full Text] [Related]

  • 7. Immunization of mice with formalin-inactivated spores from avirulent Bacillus cereus strains provides significant protection from challenge with Bacillus anthracis Ames.
    Vergis JM, Cote CK, Bozue J, Alem F, Ventura CL, Welkos SL, O'Brien AD.
    Clin Vaccine Immunol; 2013 Jan; 20(1):56-65. PubMed ID: 23114705
    [Abstract] [Full Text] [Related]

  • 8. Oral priming of mice by recombinant spores of Bacillus subtilis.
    Ciabattini A, Parigi R, Isticato R, Oggioni MR, Pozzi G.
    Vaccine; 2004 Oct 22; 22(31-32):4139-43. PubMed ID: 15474704
    [Abstract] [Full Text] [Related]

  • 9. Bacillus spores for vaccine delivery.
    Oggioni MR, Ciabattini A, Cuppone AM, Pozzi G.
    Vaccine; 2003 Jun 01; 21 Suppl 2():S96-101. PubMed ID: 12763690
    [Abstract] [Full Text] [Related]

  • 10. Oral administration of a Bacillus subtilis spore-based vaccine expressing Clonorchis sinensis tegumental protein 22.3 kDa confers protection against Clonorchis sinensis.
    Zhou Z, Xia H, Hu X, Huang Y, Li Y, Li L, Ma C, Chen X, Hu F, Xu J, Lu F, Wu Z, Yu X.
    Vaccine; 2008 Mar 28; 26(15):1817-25. PubMed ID: 18329763
    [Abstract] [Full Text] [Related]

  • 11. Bacillus subtilis comes of age as a vaccine production host and delivery vehicle.
    Rosales-Mendoza S, Angulo C.
    Expert Rev Vaccines; 2015 Mar 28; 14(8):1135-48. PubMed ID: 26028252
    [Abstract] [Full Text] [Related]

  • 12. Boosting systemic and secreted antibody responses in mice orally immunized with recombinant Bacillus subtilis strains following parenteral priming with a DNA vaccine encoding the enterotoxigenic Escherichia coli (ETEC) CFA/I fimbriae B subunit.
    Luiz WB, Cavalcante RC, Paccez JD, Souza RD, Sbrogio-Almeida ME, Ferreira RC, Ferreira LC.
    Vaccine; 2008 Jul 29; 26(32):3998-4005. PubMed ID: 18597902
    [Abstract] [Full Text] [Related]

  • 13. Potency testing of anthrax spore vaccine (living) in guinea pigs.
    Jaiswal TN, Mittal KR.
    Indian Vet J; 1979 Mar 29; 56(3):199-201. PubMed ID: 113339
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy of recombinant anthrax vaccine against Bacillus anthracis aerosol spore challenge: preclinical evaluation in rabbits and Rhesus monkeys.
    Chawla A, Midha S, Bhatnagar R.
    Biotechnol J; 2009 Mar 29; 4(3):391-9. PubMed ID: 19296443
    [Abstract] [Full Text] [Related]

  • 15. Germination-independent induction of cellular immune response by Bacillus subtilis spores displaying the C fragment of the tetanus toxin.
    Mauriello EM, Cangiano G, Maurano F, Saggese V, De Felice M, Rossi M, Ricca E.
    Vaccine; 2007 Jan 15; 25(5):788-93. PubMed ID: 17028079
    [Abstract] [Full Text] [Related]

  • 16. Gut adhesive Bacillus subtilis spores as a platform for mucosal delivery of antigens.
    Tavares Batista M, Souza RD, Paccez JD, Luiz WB, Ferreira EL, Cavalcante RC, Ferreira RC, Ferreira LC.
    Infect Immun; 2014 Apr 15; 82(4):1414-23. PubMed ID: 24421038
    [Abstract] [Full Text] [Related]

  • 17. A probiotic treatment increases the immune response induced by the nasal delivery of spore-adsorbed TTFC.
    Santos FDS, Mazzoli A, Maia AR, Saggese A, Isticato R, Leite F, Iossa S, Ricca E, Baccigalupi L.
    Microb Cell Fact; 2020 Feb 19; 19(1):42. PubMed ID: 32075660
    [Abstract] [Full Text] [Related]

  • 18. Bacterial spores as vaccine vehicles.
    Duc le H, Hong HA, Fairweather N, Ricca E, Cutting SM.
    Infect Immun; 2003 May 19; 71(5):2810-8. PubMed ID: 12704155
    [Abstract] [Full Text] [Related]

  • 19. The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions.
    Cote CK, Rossi CA, Kang AS, Morrow PR, Lee JS, Welkos SL.
    Microb Pathog; 2005 May 19; 38(5-6):209-25. PubMed ID: 15925272
    [Abstract] [Full Text] [Related]

  • 20. Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components.
    Mendelson I, Gat O, Aloni-Grinstein R, Altboum Z, Inbar I, Kronman C, Bar-Haim E, Cohen S, Velan B, Shafferman A.
    Vaccine; 2005 Dec 01; 23(48-49):5688-97. PubMed ID: 16039760
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.